Jung Wook Park

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Manish A. Shah, Kohei Shitara, Jaffer A. Ajani et al. · Nature Medicine · 2023 · 551 citations · Full text

Medicine, Oncology, Pharmacology +16

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

John K. Lee, John W. Phillips, B. Smith et al. · Cancer Cell · 2016 · 415 citations · Full text

Medicine, Cancer Biology, Oncology +12

Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage

Jung Wook Park, John K. Lee, Katherine M. Sheu et al. · Science · 2018 · 362 citations · Full text

Veterinary Medicine, Cell Biology, Oncology +17

Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies

Nikolas G. Balanis, Katherine M. Sheu, Favour N. Esedebe et al. · Cancer Cell · 2019 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +13

Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer

John K. Lee, Nathanael J. Bangayan, Timothy Chai et al. · Proceedings of the National Academy of Sciences · 2018 · 157 citations · Full text

Life Sciences, Immunology, Proteomics +16